Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02887157 · ClinicalTrials.gov registry record
Analyzing Retinal Microanatomy in ROP
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 191
- Enrollment target
NCT02887157: Completed study, sponsored by Duke University.
NCT02887157 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 191 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02887157 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 191 participants
- Enrollment target
Study Summary
Retinopathy of prematurity (ROP) is a disorder of development of the neural retina and its vasculature that may impact vision in vulnerable preterm neonates for a lifetime. This study utilizes new technology to determine visual and neurological development of very preterm infants in the intensive care nursery, during a period of rapid growth of the retina, optic nerve and brain. The long-term goal of this study is to help improve preterm infant health care via objective bedside imaging and analysis that characterizes early critical indicators of poor vision, neurological development and ROP, which will rapidly translate to better early intervention and improved future vision care.
Primary Outcome
Start-up of research imaging in the intensive care nursery using the new ultralight hand piece and swept source OCT
Interventions
- OTHER Magnetic Resonance Imaging
- DEVICE Swept Source OCT
- OTHER Scavenged blood collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2016-07-22 |
| Est. Completion | 2021-04-15 |
What the finished NCT02887157 record still lists
NCT02887157 is an observational study that tracks outcomes without assigning an intervention. The registered 191 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT02887157 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02887157 about?
NCT02887157 is a clinical study titled "Analyzing Retinal Microanatomy in ROP". Retinopathy of prematurity (ROP) is a disorder of development of the neural retina and its vasculature that may impact vision in vulnerable preterm neonates for a lifetime. This study utilizes new technology to determine visual and neurological development of very preterm infants in the intensive ca...
What is the current status of trial NCT02887157?
This trial is currently completed. The enrollment target is 191 participants. The study started on 2016-07-22. Estimated completion is 2021-04-15.
What interventions are being tested in trial NCT02887157?
The interventions under investigation include: Magnetic Resonance Imaging (OTHER), Swept Source OCT (DEVICE), Scavenged blood collection (OTHER).
Who is sponsoring clinical trial NCT02887157?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04621435 · 191 participants · Phase 1
Imaging of Solid Tumors Using FAP-2286
- NCT06810544 · 191 participants · Phase 1
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI